PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Eotaxin 2,457 Target Disease Irritable Bowel Syndrome 8,230 1 0.00 -1.00 0.00 0.54
Eotaxin 2,457 Target Target CCL3 1,427 33 0.02 -0.98 0.02 0.72
Eotaxin 2,457 Target Disease Leishmaniasis 15,049 1 0.00 -1.00 0.00 0.52
Eotaxin 2,457 Target Disease Menopause 19,680 1 0.00 -1.00 0.00 0.52
Eotaxin 2,457 Target Target Cox-2 21,583 17 0.00 -1.00 0.01 0.60
Eotaxin 2,457 Target Target CD95 4,266 5 0.00 -1.00 0.00 0.61
Eotaxin 2,457 Target Disease Malaria 56,215 8 0.00 -1.00 0.00 0.55
Eotaxin 2,457 Target Target CXCL9 1,016 17 0.01 -0.99 0.02 0.70
Eotaxin 2,457 Target Disease Neutropenia 25,934 2 0.00 -1.00 0.00 0.53
Eotaxin 2,457 Target Disease Hepatitis 163,842 12 0.00 -1.00 0.00 0.53
Eotaxin 2,457 Target Disease Dementia 66,782 7 0.00 -1.00 0.00 0.54
Eotaxin 2,457 Target Disease Sickle Cell 17,551 2 0.00 -1.00 0.00 0.54
Eotaxin 2,457 Target Target Renin 43,456 1 0.00 -1.00 0.00 0.50
Eotaxin 2,457 Target Disease Amyotrophic Lateral Sclerosis 14,006 1 0.00 -1.00 0.00 0.53
Eotaxin 2,457 Target Disease Sinusitis 12,330 9 0.00 -1.00 0.00 0.60
Eotaxin 2,457 Target Disease Asthma 109,610 749 0.05 -0.83 0.30 0.68
Eotaxin 2,457 Target Target bFGF 9,327 11 0.00 -1.00 0.00 0.61
Eotaxin 2,457 Target Disease Panic Disorder 7,455 1 0.00 -1.00 0.00 0.54
Eotaxin 2,457 Target Disease Breast Cancer 173,695 6 0.00 -1.00 0.00 0.51
Eotaxin 2,457 Target Disease Leukemia 162,805 17 0.00 -1.00 0.01 0.54
Eotaxin 2,457 Target Disease Pain 409,851 23 0.00 -1.00 0.01 0.52
Eotaxin 2,457 Target Disease Syphilis 20,217 1 0.00 -1.00 0.00 0.52
Eotaxin 2,457 Target Target Collagen 138,882 48 0.00 -0.99 0.02 0.57
Eotaxin 2,457 Target Disease Autism 20,962 4 0.00 -1.00 0.00 0.55
Eotaxin 2,457 Target Target CXCL3 145 1 0.00 -1.00 0.01 0.63
Eotaxin 2,457 Target Target Exodus-2 27 2 0.01 -0.96 0.07 0.68
Eotaxin 2,457 Target Disease Psoriasis 26,882 7 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Target CXCL11 526 6 0.01 -0.99 0.01 0.67
Eotaxin 2,457 Target Disease Itching 5,798 4 0.00 -1.00 0.00 0.59
Eotaxin 2,457 Target Disease Diabetic Retinopathy 14,494 5 0.00 -1.00 0.00 0.57
Eotaxin 2,457 Target Target Retinoic Acid Receptor Alpha 1,068 1 0.00 -1.00 0.00 0.59
Eotaxin 2,457 Target Disease Sepsis 64,798 8 0.00 -1.00 0.00 0.54
Eotaxin 2,457 Target Disease Gastritis 17,713 3 0.00 -1.00 0.00 0.55
Eotaxin 2,457 Target Target AXL 633 3 0.00 -1.00 0.00 0.64
Eotaxin 2,457 Target Disease Keratitis 10,599 3 0.00 -1.00 0.00 0.57
Eotaxin 2,457 Target Disease Rheumatoid Arthritis 78,952 13 0.00 -1.00 0.01 0.55
Eotaxin 2,457 Target Disease Headache 50,687 2 0.00 -1.00 0.00 0.51
Eotaxin 2,457 Target Disease Xerostomia 3,054 1 0.00 -1.00 0.00 0.57
Eotaxin 2,457 Target Disease Major Depressive Disorder 12,517 3 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Disease Respiratory Tract Infections 9,721 2 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Target CCL14 34 1 0.00 -0.98 0.03 0.66
Eotaxin 2,457 Target Disease Hypotension 42,123 1 0.00 -1.00 0.00 0.50
Eotaxin 2,457 Target Target APOA1 958 2 0.00 -1.00 0.00 0.62
Eotaxin 2,457 Target Disease Anemia 81,663 3 0.00 -1.00 0.00 0.51
Eotaxin 2,457 Target Disease Diabetic Nephropathy 12,496 2 0.00 -1.00 0.00 0.55
Eotaxin 2,457 Target Disease Arthritis 128,324 19 0.00 -1.00 0.01 0.55
Eotaxin 2,457 Target Disease Sleep Apnea 18,342 1 0.00 -1.00 0.00 0.52
Eotaxin 2,457 Target Disease Organ Transplantation 11,384 2 0.00 -1.00 0.00 0.55
Eotaxin 2,457 Target Target Methylenetetrahydrofolate Reductase 3,573 1 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Target 464.1 19 1 0.00 -0.97 0.05 0.66
Eotaxin 2,457 Target Target Xanthine Oxidase 8,860 2 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Disease Renal Failure 73,993 2 0.00 -1.00 0.00 0.50
Eotaxin 2,457 Target Disease Pneumonia 81,521 20 0.00 -1.00 0.01 0.56
Eotaxin 2,457 Target Target CCL2 3,560 68 0.02 -0.98 0.03 0.73
Eotaxin 2,457 Target Target Urokinase-Type Plasminogen Activator 3,939 2 0.00 -1.00 0.00 0.58
Eotaxin 2,457 Target Disease Conjunctival Disease 66 1 0.00 -0.99 0.02 0.65
Eotaxin 2,457 Target Disease Celiac Disease 8,026 1 0.00 -1.00 0.00 0.54
Eotaxin 2,457 Target Disease Relapsing Remitting Multiple Sclerosis 2,115 2 0.00 -1.00 0.00 0.60
Eotaxin 2,457 Target Target CXCL10/IP-10 114 5 0.01 -0.98 0.04 0.69
Eotaxin 2,457 Target Disease Diverticulitis 4,735 1 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Disease Sarcoidosis 19,176 4 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Target CD154 1,512 4 0.00 -1.00 0.00 0.63
Eotaxin 2,457 Target Target Eotaxin-2/CCL24 19 19 0.09 -0.22 1.00 0.76
Eotaxin 2,457 Target Target Histamine H4 Receptor 168 3 0.00 -0.99 0.02 0.66
Eotaxin 2,457 Target Target Alpha-Amylase 7,171 1 0.00 -1.00 0.00 0.54
Eotaxin 2,457 Target Disease Cholesterol 182,390 3 0.00 -1.00 0.00 0.49
Eotaxin 2,457 Target Disease Chronic Lymphocytic Leukemia 11,642 1 0.00 -1.00 0.00 0.53
Eotaxin 2,457 Target Disease Epilepsy 71,172 2 0.00 -1.00 0.00 0.50
Eotaxin 2,457 Target Disease Heartburn 3,957 2 0.00 -1.00 0.00 0.58
Eotaxin 2,457 Target Disease Hypocalcemia 6,174 1 0.00 -1.00 0.00 0.55
Eotaxin 2,457 Target Target APOE 12,771 2 0.00 -1.00 0.00 0.55
Eotaxin 2,457 Target Target Eotaxin-3/CCL26 26 26 0.10 -0.19 1.00 0.77
Eotaxin 2,457 Target Target ERK2 3,287 2 0.00 -1.00 0.00 0.59
Eotaxin 2,457 Target Target Vascular Cell Adhesion Protein 1 31 1 0.00 -0.98 0.03 0.66
Eotaxin 2,457 Target Disease Acute Coronary Syndromes 9,133 2 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Disease Allergic Rhinitis 12,280 85 0.02 -0.98 0.03 0.68
Eotaxin 2,457 Target Disease Muscle Weakness 9,178 1 0.00 -1.00 0.00 0.54
Eotaxin 2,457 Target Disease Hyperlipidemia 15,317 1 0.00 -1.00 0.00 0.52
Eotaxin 2,457 Target Disease Scabies 2,670 1 0.00 -1.00 0.00 0.57
AKT3 293 Target Target ERBB3 1,154 3 0.01 -0.99 0.01 0.68
AKT3 293 Target Disease Brain Tumors 16,749 1 0.00 -1.00 0.00 0.57
AKT3 293 Target Target bFGF 9,327 1 0.00 -1.00 0.00 0.58
AKT3 293 Target Disease Breast Cancer 173,695 28 0.00 -0.95 0.10 0.59
AKT3 293 Target Disease Leukemia 162,805 6 0.00 -0.99 0.02 0.56
AKT3 293 Target Disease Pain 409,851 1 0.00 -1.00 0.00 0.50
AKT3 293 Target Disease Autism 20,962 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Disease Amyotrophic Lateral Sclerosis 14,006 3 0.00 -0.99 0.01 0.60
AKT3 293 Target Target EGF 27,487 8 0.00 -0.99 0.03 0.61
AKT3 293 Target Target Cox-2 21,583 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Disease Hepatitis 163,842 1 0.00 -1.00 0.00 0.51
AKT3 293 Target Target Collagen 138,882 6 0.00 -0.99 0.02 0.56
AKT3 293 Target Disease Cholesterol 182,390 1 0.00 -1.00 0.00 0.51
AKT3 293 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -1.00 0.00 0.53
AKT3 293 Target Disease Salivary Gland Cancer 202 1 0.00 -1.00 0.00 0.70
AKT3 293 Target Disease Sarcoidosis 19,176 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Disease Epilepsy 71,172 4 0.00 -0.99 0.01 0.57
AKT3 293 Target Target BRAF 4,766 8 0.01 -0.99 0.03 0.67
AKT3 293 Target Disease Lung Cancer 91,416 9 0.00 -0.98 0.03 0.58
AKT3 293 Target Disease Seizures 66,465 5 0.00 -0.99 0.02 0.57
AKT3 293 Target Target Glutathione S-Transferase Mu 2 8 1 0.02 -0.93 0.12 0.74